{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:49:09Z","timestamp":1788522549198,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ajogmf.2021.100518","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T08:22:49Z","timestamp":1634890969000},"page":"100518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exposure to biologic therapy and associated maternal and neonatal outcomes in pregnancies complicated by inflammatory bowel disease"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4648-0583","authenticated-orcid":false,"given":"Patricia","family":"Rekawek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaelyn","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6279-8172","authenticated-orcid":false,"given":"Catherine A.","family":"Bigelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3680-7397","authenticated-orcid":false,"given":"Chloe","family":"Getrajdman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Roy-McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Stoffels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla C.","family":"Dubinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T.","family":"Mella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2021.100518_bib0001","article-title":"The impact of pregnancy on biologic therapies for the treatment of inflammatory bowel disease","volume":"44\u20135","author":"Picardo","year":"2020","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0002","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/j.1572-0241.1998.00698.x","article-title":"Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries","volume":"93","author":"Fonager","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0003","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cgh.2010.02.014","article-title":"Crohn's disease is a risk factor for preterm birth","volume":"8","author":"Stephansson","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0004","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gut.2006.108324","article-title":"A meta-analysis on the influence of inflammatory bowel disease on pregnancy","volume":"56","author":"Cornish","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0005","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ibd.21369","article-title":"Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden","volume":"17","author":"Stephansson","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0006","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/j.gastro.2007.07.019","article-title":"Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California","volume":"133","author":"Mahadevan","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0007","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3109\/00365521.2010.503967","article-title":"Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: a case-control study","volume":"45","author":"Moln\u00e1r","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0008","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2147\/CEG.S96676","article-title":"Managing inflammatory bowel disease in pregnancy: current perspectives","volume":"9","author":"Pinder","year":"2016","journal-title":"Clin Exp Gastroenterol"},{"issue":"Suppl1","key":"10.1016\/j.ajogmf.2021.100518_bib0009","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1136\/gut.2005.081950c","article-title":"European evidence based consensus on the diagnosis and management of Crohn's disease: special situations","volume":"55","author":"Caprilli","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0010","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2013.07.041","article-title":"Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies","volume":"145","author":"Frolkis","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0011","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.crohns.2010.04.004","article-title":"Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects","volume":"4","author":"Allez","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0012","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/ecco-jcc\/jjw052","article-title":"Perceptions and attitudes towards medication adherence during pregnancy in inflammatory bowel disease","volume":"10","author":"Gallinger","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0013","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0016-5085(12)60561-7","article-title":"PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy","volume":"142","author":"Mahadevan","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0014","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT\u2122 registry","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0015","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/apt.12936","article-title":"Maternal and foetal adverse events with tumour necrosis factor-alpha inhibitors in inflammatory bowel disease","volume":"40","author":"Deepak","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0016","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/ibd.21583","article-title":"Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy","volume":"17","author":"Schnitzler","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0017","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/apt.12833","article-title":"Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease","volume":"40","author":"Seirafi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0018","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/ecco-jcc\/jjv234","article-title":"Anti-tumour necrosis factor \u03b1 therapies and inflammatory bowel disease pregnancy outcomes: a meta-analysis","volume":"10","author":"Shihab","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0019","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/MIB.0000000000000092","article-title":"Anti-TNF\u03b1 therapies are safe during pregnancy in women with inflammatory bowel disease: a systematic review and meta-analysis","volume":"20","author":"Narula","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0020","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/cid\/ciu185","article-title":"Biologic therapies in rheumatoid arthritis and the risk of opportunistic infections: a meta-analysis","volume":"58","author":"Kourbeti","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0021","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s41395-018-0176-7","article-title":"Continuous anti-TNF\u03b1 use throughout pregnancy: possible complications for the mother but not for the fetus. A retrospective cohort on the French national health insurance database (Evasion)","volume":"113","author":"Luu","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0022","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1055\/s-0034-1543953","article-title":"Risk factors for prolonged postpartum length of stay following cesarean delivery","volume":"32","author":"Blumenfeld","year":"2015","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0023","article-title":"Biologics for inflammatory bowel disease and their safety in pregnancy: a systematic review and meta-analysis","author":"Nielsen","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"suppl_2","key":"10.1016\/j.ajogmf.2021.100518_bib0024","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jcag\/gwy009.104","article-title":"A104 pregnancy outcomes in women with inflammatory bowel disease and exposure to biologics - a prospective cohort study","volume":"1","author":"Wang","year":"2018","journal-title":"J Can Assoc Gastroenterol"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1060028018754896","article-title":"Biologic-induced infections in inflammatory bowel disease: the TNF-\u03b1 antagonists","volume":"52","author":"McConachie","year":"2018","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ajogmf.2021.100518_bib0026","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3748\/wjg.v26.i12.1231","article-title":"Venous thromboembolism in inflammatory bowel disease","volume":"26","author":"Cheng","year":"2020","journal-title":"World J Gastroenterol"}],"container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933321002135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933321002135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:47:47Z","timestamp":1762904867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933321002135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2589933321002135"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2021.100518","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposure to biologic therapy and associated maternal and neonatal outcomes in pregnancies complicated by inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2021.100518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100518"}}